HIV & smoking in India

S. Ramesh Kumar, Soumya Swaminathan, Timothy Flanigan, K. H. Mayer, Raymond Niaura

Research output: Contribution to journalReview article

Abstract

There are approximately 2.5 million people living with HIV/AIDS (PLWHA) in India - the young being particularly vulnerable. The prevalence of smoking has increased in India especially among rural, lower socio-economic and illiterate men. Studies have shown that HIV-infected smokers may be at additional risk for several infectious and non-infectious complications, including malignancies and cardiovascular events. Smoking alters immunological mechanisms and suppresses host defenses in the alveolar environment. HIV-infected smokers have also been found to have a poorer response to antiretroviral therapy and a higher risk of death. HIV-infected individuals who smoke could be at a greater risk for developing TB and subsequently suffer higher morbidity and mortality than those who do not smoke. Currently available smoking cessation interventions like physician's advice, nicotine replacement therapy and pharmacological agents like bupropion and varenicline have had varying degrees of success. Smoking cessation intervention in the HIV-infected population might be more complex because of associated psychosocial problems like drug addiction, alcoholism, depression, etc. More research including clinical trials testing the efficacy of smoking cessation interventions in HIV-infected persons is required in India. In addition to public health measures like banning smoking in public places and raising tobacco tax, comprehensive guidelines for health workers can help address this problem. Counselling on smoking cessation should be one of the main components of primary care, especially in the management of HIV-infected persons. This review highlights the importance of smoking cessation among HIV-infected persons in India.

Original languageEnglish (US)
Pages (from-to)15-22
Number of pages8
JournalIndian Journal of Medical Research
Volume130
Issue number1
StatePublished - 2009

Fingerprint

India
Smoking
HIV
Smoking Cessation
Smoke
Bupropion
Tobacco
Public health
Taxation
Nicotine
Health
Economics
Testing
Pharmaceutical Preparations
Alcoholism
Substance-Related Disorders
Counseling
Primary Health Care
Acquired Immunodeficiency Syndrome
Public Health

Keywords

  • HIV
  • India
  • Smoking cessation
  • Tobacco
  • Tuberculosis

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ramesh Kumar, S., Swaminathan, S., Flanigan, T., Mayer, K. H., & Niaura, R. (2009). HIV & smoking in India. Indian Journal of Medical Research, 130(1), 15-22.

HIV & smoking in India. / Ramesh Kumar, S.; Swaminathan, Soumya; Flanigan, Timothy; Mayer, K. H.; Niaura, Raymond.

In: Indian Journal of Medical Research, Vol. 130, No. 1, 2009, p. 15-22.

Research output: Contribution to journalReview article

Ramesh Kumar, S, Swaminathan, S, Flanigan, T, Mayer, KH & Niaura, R 2009, 'HIV & smoking in India', Indian Journal of Medical Research, vol. 130, no. 1, pp. 15-22.
Ramesh Kumar S, Swaminathan S, Flanigan T, Mayer KH, Niaura R. HIV & smoking in India. Indian Journal of Medical Research. 2009;130(1):15-22.
Ramesh Kumar, S. ; Swaminathan, Soumya ; Flanigan, Timothy ; Mayer, K. H. ; Niaura, Raymond. / HIV & smoking in India. In: Indian Journal of Medical Research. 2009 ; Vol. 130, No. 1. pp. 15-22.
@article{87cf7b82fb6749a399b778e6b11a68cb,
title = "HIV & smoking in India",
abstract = "There are approximately 2.5 million people living with HIV/AIDS (PLWHA) in India - the young being particularly vulnerable. The prevalence of smoking has increased in India especially among rural, lower socio-economic and illiterate men. Studies have shown that HIV-infected smokers may be at additional risk for several infectious and non-infectious complications, including malignancies and cardiovascular events. Smoking alters immunological mechanisms and suppresses host defenses in the alveolar environment. HIV-infected smokers have also been found to have a poorer response to antiretroviral therapy and a higher risk of death. HIV-infected individuals who smoke could be at a greater risk for developing TB and subsequently suffer higher morbidity and mortality than those who do not smoke. Currently available smoking cessation interventions like physician's advice, nicotine replacement therapy and pharmacological agents like bupropion and varenicline have had varying degrees of success. Smoking cessation intervention in the HIV-infected population might be more complex because of associated psychosocial problems like drug addiction, alcoholism, depression, etc. More research including clinical trials testing the efficacy of smoking cessation interventions in HIV-infected persons is required in India. In addition to public health measures like banning smoking in public places and raising tobacco tax, comprehensive guidelines for health workers can help address this problem. Counselling on smoking cessation should be one of the main components of primary care, especially in the management of HIV-infected persons. This review highlights the importance of smoking cessation among HIV-infected persons in India.",
keywords = "HIV, India, Smoking cessation, Tobacco, Tuberculosis",
author = "{Ramesh Kumar}, S. and Soumya Swaminathan and Timothy Flanigan and Mayer, {K. H.} and Raymond Niaura",
year = "2009",
language = "English (US)",
volume = "130",
pages = "15--22",
journal = "Indian Journal of Medical Research",
issn = "0971-5916",
publisher = "Indian Council of Medical Research",
number = "1",

}

TY - JOUR

T1 - HIV & smoking in India

AU - Ramesh Kumar, S.

AU - Swaminathan, Soumya

AU - Flanigan, Timothy

AU - Mayer, K. H.

AU - Niaura, Raymond

PY - 2009

Y1 - 2009

N2 - There are approximately 2.5 million people living with HIV/AIDS (PLWHA) in India - the young being particularly vulnerable. The prevalence of smoking has increased in India especially among rural, lower socio-economic and illiterate men. Studies have shown that HIV-infected smokers may be at additional risk for several infectious and non-infectious complications, including malignancies and cardiovascular events. Smoking alters immunological mechanisms and suppresses host defenses in the alveolar environment. HIV-infected smokers have also been found to have a poorer response to antiretroviral therapy and a higher risk of death. HIV-infected individuals who smoke could be at a greater risk for developing TB and subsequently suffer higher morbidity and mortality than those who do not smoke. Currently available smoking cessation interventions like physician's advice, nicotine replacement therapy and pharmacological agents like bupropion and varenicline have had varying degrees of success. Smoking cessation intervention in the HIV-infected population might be more complex because of associated psychosocial problems like drug addiction, alcoholism, depression, etc. More research including clinical trials testing the efficacy of smoking cessation interventions in HIV-infected persons is required in India. In addition to public health measures like banning smoking in public places and raising tobacco tax, comprehensive guidelines for health workers can help address this problem. Counselling on smoking cessation should be one of the main components of primary care, especially in the management of HIV-infected persons. This review highlights the importance of smoking cessation among HIV-infected persons in India.

AB - There are approximately 2.5 million people living with HIV/AIDS (PLWHA) in India - the young being particularly vulnerable. The prevalence of smoking has increased in India especially among rural, lower socio-economic and illiterate men. Studies have shown that HIV-infected smokers may be at additional risk for several infectious and non-infectious complications, including malignancies and cardiovascular events. Smoking alters immunological mechanisms and suppresses host defenses in the alveolar environment. HIV-infected smokers have also been found to have a poorer response to antiretroviral therapy and a higher risk of death. HIV-infected individuals who smoke could be at a greater risk for developing TB and subsequently suffer higher morbidity and mortality than those who do not smoke. Currently available smoking cessation interventions like physician's advice, nicotine replacement therapy and pharmacological agents like bupropion and varenicline have had varying degrees of success. Smoking cessation intervention in the HIV-infected population might be more complex because of associated psychosocial problems like drug addiction, alcoholism, depression, etc. More research including clinical trials testing the efficacy of smoking cessation interventions in HIV-infected persons is required in India. In addition to public health measures like banning smoking in public places and raising tobacco tax, comprehensive guidelines for health workers can help address this problem. Counselling on smoking cessation should be one of the main components of primary care, especially in the management of HIV-infected persons. This review highlights the importance of smoking cessation among HIV-infected persons in India.

KW - HIV

KW - India

KW - Smoking cessation

KW - Tobacco

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=70349532818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349532818&partnerID=8YFLogxK

M3 - Review article

C2 - 19700796

AN - SCOPUS:70349532818

VL - 130

SP - 15

EP - 22

JO - Indian Journal of Medical Research

JF - Indian Journal of Medical Research

SN - 0971-5916

IS - 1

ER -